Barclays Portfolio holdings
Barclays PLC, founded in 1690 by goldsmith bankers in London, is a British multinational financial institution headquartered in London, operating as one of the world’s oldest banks with a significant presence in investment banking, retail banking, and wealth management. Managing billions in assets, Barclays serves millions of customers globally through its retail arm (notably in the UK) and its investment banking division, which excels in trading, mergers and acquisitions, and capital markets, competing with Wall Street giants. The bank has navigated challenges like the 2008 financial crisis—opting for private funding over a government bailout—and has since focused on restructuring, digital innovation, and sustainable finance initiatives. With a rich history and a modern global footprint, Barclays remains a key player in both UK and international financial markets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares 20+ Year Treasury Bond ETF
TLT
|
+$1.46B |
| 2 |
NVIDIA
NVDA
|
+$1.08B |
| 3 |
State Street Health Care Select Sector SPDR ETF
XLV
|
+$609M |
| 4 |
Moderna
MRNA
|
+$599M |
| 5 |
UBS Group
UBS
|
+$478M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.11B |
| 2 |
Apple
AAPL
|
+$679M |
| 3 |
Palo Alto Networks
PANW
|
+$450M |
| 4 |
Alphabet (Google) Class A
GOOGL
|
+$428M |
| 5 |
Microsoft
MSFT
|
+$361M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 14.97% |
| 2 | Financials | 8.75% |
| 3 | Healthcare | 7.15% |
| 4 | Consumer Discretionary | 6.46% |
| 5 | Communication Services | 5.81% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2626
Aspen Aerogels
ASPN
$384M
| $1.33M | ﹤0.01% |
26,769
+17,756
| +197% | +$936K |
|
2627
Integra LifeSciences
IART
$1.29B
| $1.33M | ﹤0.01% |
19,885
-25,644
| -56% | -$1.73M |
|
2628
Clean Energy Fuels
CLNE
$427M
| $1.33M | ﹤0.01% |
217,266
+79,600
| +58% | +$624K |
|
|
WSR
2629
DELISTED
Whitestone REIT
WSR
| $1.33M | ﹤0.01% |
131,433
-52,418
| -29% | -$511K |
|
2630
CALL
LivaNova
LIVN
$4.4B
| $1.33M | ﹤0.01% |
+15,200
| New | +$1.27M |
|
2631
Milestone Pharmaceuticals
MIST
$138M
| $1.33M | ﹤0.01% |
203,013
+2,325
| +1% | +$13.9K |
|
2632
First Community Bankshares
FCBC
$900M
| $1.33M | ﹤0.01% |
39,735
+13,206
| +50% | +$440K |
|
|
MOFG
2633
DELISTED
MidWestOne Financial Group
MOFG
| $1.32M | ﹤0.01% |
40,913
+8,961
| +28% | +$287K |
|
2634
Midland States Bancorp
MSBI
$699M
| $1.32M | ﹤0.01% |
53,381
+25,184
| +89% | +$632K |
|
2635
Douglas Dynamics
PLOW
$1.02B
| $1.32M | ﹤0.01% |
33,876
+14,987
| +79% | +$605K |
|
2636
PUT
Murphy Oil
MUR
$5.7B
| $1.32M | ﹤0.01% |
+50,600
| New | +$1.4M |
|
2637
PUT
ProShares Trust UltraShort Lehman 20+ Year Treasury
TBT
$304M
| $1.32M | ﹤0.01% |
78,200
| – | – |
|
|
FFIC
2638
DELISTED
Flushing Financial
FFIC
| $1.32M | ﹤0.01% |
54,344
+24,609
| +83% | +$588K |
|
2639
Archrock
AROC
$6.27B
| $1.32M | ﹤0.01% |
176,048
+33,102
| +23% | +$266K |
|
2640
Weis Markets
WMK
$1.91B
| $1.31M | ﹤0.01% |
19,969
+12,640
| +172% | +$767K |
|
2641
Allison Transmission
ALSN
$9.5B
| $1.31M | ﹤0.01% |
36,090
-98,549
| -73% | -$3.48M |
|
2642
MannKind Corp
MNKD
$1.21B
| $1.31M | ﹤0.01% |
299,709
+191,361
| +177% | +$885K |
|
2643
CEVA Inc
CEVA
$910M
| $1.31M | ﹤0.01% |
30,235
+10,968
| +57% | +$490K |
|
|
VIVO
2644
DELISTED
Meridian Bioscience Inc
VIVO
| $1.31M | ﹤0.01% |
64,132
+21,545
| +51% | +$413K |
|
2645
CALL
Strategy Inc
MSTR
$34.1B
| $1.31M | ﹤0.01% |
+24,000
| New | +$1.65M |
|
2646
CALL
NextEra Energy
NEE
$181B
| $1.31M | ﹤0.01% |
+14,000
| New | +$1.21M |
|
2647
Axalta
AXTA
$7.66B
| $1.3M | ﹤0.01% |
39,379
-142,368
| -78% | -$4.52M |
|
|
ZEN
2648
PUT
DELISTED
ZENDESK INC
ZEN
| $1.3M | ﹤0.01% |
12,500
| – | – |
|
2649
FIVE9
FIVN
$2.11B
| $1.3M | ﹤0.01% |
9,485
-47,255
| -83% | -$6.99M |
|
|
CCRN
2650
DELISTED
Cross Country Healthcare
CCRN
| $1.3M | ﹤0.01% |
46,856
+14,363
| +44% | +$348K |
|
Similar funds
Barclays's Q4 2021 Portfolio in Review
As of Q4 2021, Barclays held 5,008 positions worth $268B, up 21% from $222B the previous quarter. Its ten largest holdings account for 30% of the portfolio.
Barclays deployed $30.5B of net new capital in Q4 2021, opening 209 new positions and adding to 2,223 existing holdings. Its largest new stake was UBS Group: 27,173,428 shares worth $486M.
By sector, the portfolio is most concentrated in Technology at 15% of assets, up from 14% a quarter earlier, followed by Financials and Healthcare.
On the sell side, the largest reduction was State Street SPDR S&P 500 ETF Trust, an estimated $1.11B trimmed.
- Barclays's largest Q4 2021 buy was UBS Group: 27,173,428 shares worth $486M.
- Barclays added most to iShares 20+ Year Treasury Bond ETF in Q4 2021, an estimated $1.46B increase.
- Barclays's biggest Q4 2021 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $1.11B.
- Barclays fully exited Vanguard Total International Bond ETF in Q4 2021, selling an estimated $89.8M.
- Barclays's ten largest holdings make up 30% of its $268B portfolio in Q4 2021.
- Barclays opened 209 new positions and closed 867 in Q4 2021.
- Barclays's portfolio value rose 21% quarter-over-quarter to $268B.
Based on Barclays's 13F filing for Q4 2021, filed 14 Feb 2022.